Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Reata Pharmaceuticals Resource Report Resource Website 1+ mentions |
Reata Pharmaceuticals (RRID:SCR_004040) | Reata | commercial organization | Pharmaceutical company focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) and inhibit the pro-inflammatory transcription factor NF-B (nuclear factor kappa-light-chain-enhancer of activated B cells). The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in their portfolio. | pharmaceutical, drug, immuno-oncology, ophthalmology, cardiovascular, autoimmune, respiratory, antioxidant inflammation modulator, oxidative stress, medicine, dermatology, skin, eye, clinical trial, nrf2, nf-b, bardoxolone methyl, rta 408, transcription, dna, transcription factor | is related to: Kidney Health Initiative | nlx_158468 | SCR_004040 | Reata Pharmaceuticals Inc. | 2026-02-14 02:00:55 | 2 | ||||||||
|
Otsuka America Pharmaceutical Inc. Resource Report Resource Website 1+ mentions |
Otsuka America Pharmaceutical Inc. (RRID:SCR_004036) | OAPI | commercial organization | Healthcare company that oversees all pharmaceutical and medical device commercial activities of Otsuka Group (Otsuka) in North America. Products with emphasis on neuroscience, oncology, cardio-renal, and medical device markets. | pharmaceutical, medical device, neuroscience, oncology, cardio-renal, commercial | is related to: Kidney Health Initiative | nlx_158462 | http://www.otsuka-us.com/Companies/OAPI/ | SCR_004036 | Otsuka America Pharmaceutical | 2026-02-14 02:00:55 | 1 | |||||||
|
Proteon Therapeutics Resource Report Resource Website 1+ mentions |
Proteon Therapeutics (RRID:SCR_004037) | Proteon | commercial organization | A biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases. Their ongoing Phase 3 clinical trial is evaluating whether a single treatment of PRT-201 can reduce vascular access failure, one of the most serious problems experienced by patients with chronic kidney disease (CKD) undergoing hemodialysis. PRT-201 is an investigational drug that may inhibit neointimal hyperplasia, the growth of tissue inside blood vessels that can result in vessel narrowing and reduced blood flow. PRT-201 has received fast track and orphan drug designations for hemodialysis vascular access indications.In September 2019, Proteon Therapeutics merged with ArTara Therapeutics. | biopharmaceutical, pharmaceutical, hemodialysis, prt-201, drug |
is related to: Kidney Health Initiative is related to: Protara Therapeutics |
Kidney disease, Vascular disease, Chronic kidney disease, Neointimal hyperplasia, Peripheral arterial disease | nlx_158465 | SCR_004037 | Proteon Therapeutics Inc. | 2026-02-14 02:00:35 | 1 | |||||||
|
Endocells Resource Report Resource Website 10+ mentions |
Endocells (RRID:SCR_004067) | Endocells | commercial organization | This resource no longer in service. Documented on August 12, 2021. French biotech company dedicated to human endocrine cell line production with a first focus on human pancreatic beta cell. Other cell types are being prepared like glucagon cells. The material will be powerful tools for drug discovery, toxicology and cell replacement therapy. Achievements to date * Generated tumoral and non-tumoral human beta cell lines which closely resemble human primary pancreatic beta cells (using technologies which have been first developed and validated using immortalized rat beta cell lines). World first. * Established a robust technology platform which will be used to develop other human endocrine cell lines. | pancreas, endocrine system, replacement cell therapy, glucagon, drug discovery, toxicology, pancreatic beta cell, cell line, human endocrine cell line, beta cell, glucagon cell, tumor |
is listed by: One Mind Biospecimen Bank Listing is related to: IMIDIA |
nlx_158504 | SCR_004067 | Endocells SARL, SARL Endocells | 2026-02-14 02:00:36 | 15 | ||||||||
|
Genomedics Resource Report Resource Website |
Genomedics (RRID:SCR_004103) | Genomedics | commercial organization | A commercial company specialized in the field of clinical governance, research and clinical-epidemiological analysis and development of services and software applications for healthcare. Products and Services * Analysis and development software solutions, web, e-learning * Design and Implementation APP for Smartphone and Tablet (iOS, Android, Windows Phone) * Clinical Intelligence & Clinical Decision Support Systems (CDSS) * Data center services and Application Server Provider * Epidemiology, Surveillance and Health Promotion - Development of studies and epidemiological research | healthcare, clinical, medicine, health, information service, analysis, software development, web portal, multimedia, e-learning, data center service, application server, business intelligence, epidemiology, surveillance, health promotion, population | is related to: EMIF | nlx_158578 | SCR_004103 | Genomedics health care consultants, Genomedics S.r.l. | 2026-02-14 02:00:40 | 0 | ||||||||
|
European ScreeningPort Resource Report Resource Website |
European ScreeningPort (RRID:SCR_004061) | ESP | commercial organization | Commercial organization that aims to bridge the gap between academia and the life-sciences industry with a wide ranging experience in pharmaceutical industry R&D covering multiple target classes and therapeutic areas. This deep scientific insight and established links with world class research institutions is applied across their business groups: * Drug Discovery * Biomarker and Translational Research * Enabling Technologies * R&D Information Technologies They measure their performance by successful outcomes for their collaborators, and recognize that an authentic partnership approach is essential in achieving the goal of converting outstanding science into high quality starting points for new medicines. | pharmaceutical |
is related to: Kinetics for Drug Discovery has parent organization: Mainz Institute of Molecular Biology Bioinformatics Core Facility |
German Federal Ministry of Education and Research ; Norgenta |
nlx_158497 | SCR_004061 | European Screening Port, European Screening Port GmbH, European ScreeningPort GmbH | 2026-02-14 02:00:40 | 0 | |||||||
|
W. L. Gore and Associates Resource Report Resource Website 1+ mentions |
W. L. Gore and Associates (RRID:SCR_004060) | Gore | commercial organization | An American manufacturing company specializing in products derived from fluoropolymers that focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. | medical device, implant, copper, optical, signal transmission, electronic, fabric, industrial product, medical product, contamination | is related to: Kidney Health Initiative | nlx_158494 | SCR_004060 | W. L. Gore & Associates Inc., W.L. Gore & Associates Inc., W.L. Gore and Associates, W. L. Gore & Associates, W.L. Gore & Associates | 2026-02-14 02:00:54 | 1 | ||||||||
|
Sierra Sensors Resource Report Resource Website 1+ mentions |
Sierra Sensors (RRID:SCR_004062) | commercial organization | In 2018 Bruker acquired Sierra Sensors GmbH, based in Hamburg, Germany. Sierra develops and manufactures innovative analytical biosensors based on Surface Plasmon Resonance (SPR) detection. Driven by patented technologies in the areas of SPR detection and microfluidic sample delivery, Sierra instruments are setting a new standard in high-throughput and high-performance label-free analysis. | biosensor, analytical tool, molecule, interaction, label-free analysis, analysis, assay, microfluidic, diagnostic | is related to: Kinetics for Drug Discovery | nlx_158499 | SCR_004062 | Sierra Sensors Biosensor Technologies, Sierra Sensors GmbH | 2026-02-14 02:00:55 | 1 | |||||||||
|
National Cancer Research Institute Resource Report Resource Website 1+ mentions |
National Cancer Research Institute (RRID:SCR_004057) | NCRI | institution | The National Cancer Research Institute (NCRI) is a UK-wide partnership between the government, charity and industry which promotes co-operation in cancer research among the 22 member organizations for the benefit of patients, the public and the scientific community. Cancer affects everyone. One third of people in the UK get cancer at some time in their lives and a quarter of all people die from it. This means that even if we don''t have cancer ourselves, we know someone who does, or soon will. | is parent organization of: onCore UK | Crossref funder ID: 100008667, Wikidata: Q6971241, ISNI: 0000 0004 0578 6831, grid.451262.6, nlx_143544 | https://ror.org/02mp0vf47 | http://www.ncri.org.uk/default.asp | SCR_004057 | NCRI - National Cancer Research Institute | 2026-02-14 02:00:40 | 1 | |||||||
|
Vasculitis Foundation Resource Report Resource Website |
Vasculitis Foundation (RRID:SCR_004059) | VF | institution | An international organization for patients with vasculitis, their families, friends and the health care professionals who care for them, supporting and empowering them through education, awareness and research. The Foundation advocates for early diagnosis and leading edge treatment for all. The Foundation also partners with researchers around the world to determine the cause and discover the cure for vasculitis. | clinical, pediatric, child, funding resource | is related to: Kidney Health Initiative | Vasculitis | Crossref funder ID: 100007211, grid.453926.f, nlx_158493 | https://ror.org/03f9wqe45 | SCR_004059 | 2026-02-14 02:00:36 | 0 | |||||||
|
Boston University; Massachusetts; USA Resource Report Resource Website 1+ mentions |
Boston University; Massachusetts; USA (RRID:SCR_004054) | BU | university | Private research university in Boston, Massachusetts. The university is nonsectarian but maintains its historical affiliation with the United Methodist Church. It was founded in 1839 by Methodists with its original campus in Newbury, Vermont, before moving to Boston in 1867. |
uses: ResearchConnection is used by: ResearchConnection is related to: Alzheimers Disease Genetics Consortium is related to: International AMD Genetics Consortium is related to: Clinical and Translational Science Awards Consortium is related to: Piirus is parent organization of: EarLab is parent organization of: Evolutionary Lineage Inferred from Structural Analysis is parent organization of: Speech Language Disorders Database is parent organization of: Boston University Medical Campus; Massachusetts; USA is parent organization of: StellaBase: Nematostella vactensis genomics database is parent organization of: Tandem Repeats Database is parent organization of: Yeast Mitochondrial Protein Database is parent organization of: Boston University Department of Neuroscience is parent organization of: Many Microbe Microarrays Database is parent organization of: PRECISE is parent organization of: SIEGE- Smoking Induced Epithelial Gene Expression is parent organization of: Visionary: A Dictionary for the Study of Vision is parent organization of: Framingham Heart Study is parent organization of: Boston University School of Medicine; Massachusetts; USA is parent organization of: Boston University Labs and Facilities is parent organization of: Boston University Microarray Resource Core is parent organization of: CnidBase is parent organization of: OBART is parent organization of: Graph Theory GLM (GTG) MATLAB Toolbox is parent organization of: ClusPro is parent organization of: openEyeTrack project is parent organization of: Boston University Microarray and Sequencing Resource Core Facility is parent organization of: Teensy-Based Interface project |
Crossref funder ID:100007161, grid.189504.1, ISNI:0000 0004 1936 7558, nlx_75713, Wikidata:Q49110 | https://ror.org/05qwgg493 | SCR_004054 | Boston University | 2026-02-14 02:00:36 | 6 | ||||||||
|
University of Lodz; Lodz; Poland Resource Report Resource Website |
University of Lodz; Lodz; Poland (RRID:SCR_004053) | university | Public research university founded in 1945 in Łódź, Poland, as a continuation of educational institutions functioning in Łódź in the interwar period — the Teacher Training Institute, the Higher School of Social and Economic Sciences and a division of the Free Polish University. |
is related to: AddNeuroMed is related to: EARIP |
ISNI:0000 0000 9730 2769, grid.10789.37, nlx_158123, Crossref funder ID:501100005643, Wikidata:Q137503 | https://ror.org/05cq64r17 | SCR_004053 | Uniwersytet �dzki, University of �d, University of Lodz | 2026-02-14 02:00:55 | 0 | |||||||||
|
Thrasos Therapeutics Resource Report Resource Website |
Thrasos Therapeutics (RRID:SCR_004052) | Thrasos | commercial organization | Private, clinical stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. They are committed to developing novel approaches to protect, treat and restore kidney function for this patient group. Company has designed specific class of peptide compounds that have shown excellent results in controlling experimental kidney diseases, notably, models of diabetic nephropathy (kidney damage associated with diabetes), and acute kidney injury. These proprietary peptides may therefore be able to prevent and treat acute kidney injury, as well as slow and possibly reverse the progression of diabetic nephropathy. They act to control apoptosis (programmed cell death), inflammation and fibrosis (formation of scar tissue). | Controlling experimental kidney diseases, biotherapeutics, clinical, peptide, treat acute kidney injury, reverse progression diabetic nephropathy | is related to: Kidney Health Initiative | Kidney disease, Acute kidney injury, Diabetic nephropathy, Chronic kidney disease | nlx_158489 | http://www.thrasos.com/ | SCR_004052 | Thrasos Innovation Inc. | 2026-02-14 02:00:40 | 0 | ||||||
|
American Psychological Association Resource Report Resource Website 1000+ mentions |
American Psychological Association (RRID:SCR_004083) | APA | professional organization | Based in Washington, D.C., the American Psychological Association (APA) is a scientific and professional organization that represents psychology in the United States. With more than 154,000 members, APA is the largest association of psychologists worldwide. The mission of the APA is to advance the creation, communication and application of psychological knowledge to benefit society and improve people''s lives. The American Psychological Association aspires to excel as a valuable, effective and influential organization advancing psychology as a science, serving as: * A uniting force for the discipline * The major catalyst for the stimulation, growth and dissemination of psychological science and practice * The primary resource for all psychologists * The premier innovator in the education, development, and training of psychological scientists, practitioners and educators * The leading advocate for psychological knowledge and practice informing policy makers and the public to improve public policy and daily living * A principal leader and global partner promoting psychological knowledge and methods to facilitate the resolution of personal, societal and global challenges in diverse, multicultural and international contexts * An effective champion of the application of psychology to promote human rights, health, well being and dignity APA and its affiliate organizations provide a diverse range of scholarships, grants, and awards with the aim of advancing research in psychology. Using our specialized search tool, you can find funding by type, sponsor, topic area, recipient type, and deadline date. | is parent organization of: PsycINFO | Crossref funder ID: 100006324, Wikidata: Q466587, nlx_143547, grid.280937.7, ISNI: 0000 0001 2166 7523 | https://ror.org/00rt1d436 | SCR_004083 | 2026-02-14 02:00:54 | 1763 | |||||||||
|
Inspiralis Resource Report Resource Website 1+ mentions |
Inspiralis (RRID:SCR_004082) | commercial organization | Commercial organization supplying topoisimerase products and services to the pharmaceutical industry and academia to aid research in the anti-infectives and anti-cancer markets. Their aim is to provide pharmaceutical companies, and others involved in drug development, with the necessary tools to develop and screen novel anti-infective and anti-cancer compounds. Products All their proteins are expressed as the native sequences without additional tags. The only exception is the M. tuberculosis gyrase which is currently produced with a C-terminal His tag. An untagged version of this protein will be available soon. * Topoisomerase Enzymes and Assay Kits * Specific Gyrase Protein Domains * DNA Substrates and Markers * Antibodies Services * Gel Based Assays * Medium / High Throughput Assay * Investigation protein DNA interaction ReDCaT chip | topoisomerase, enzyme, substrate, drug development, anti-infective, anti-cancer, assay, protein-dna interaction, protein, dna | is related to: European Gram Negative AntiBacterial Engine | nlx_158540 | SCR_004082 | Inspiralis Limited, Inspiralis Ltd | 2026-02-14 02:00:36 | 3 | |||||||||
|
Biomol-Informatics Resource Report Resource Website 1+ mentions |
Biomol-Informatics (RRID:SCR_004081) | commercial organization | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on August 12, 2021. Technology based company in Madrid that offers consulting services on Bioinformatics in areas of research, diagnostics and pharmaceutical industry. | bioinformatics, genome sequencing, genome, sequencing, exome, protein-protein interaction, analysis, molecular dynamics, 3d modeling, evolutive information, training service resource, next generation sequencing, simulation, drug design, computational simulation, macromolecule, molecular dynamics, quantum mechanics, molecular mechanics, dna, protein |
is related to: European Gram Negative AntiBacterial Engine has parent organization: Autonomous University of Madrid; Madrid; Spain |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158539, grid.432020.7, Wikidata Q30254873 | https://ror.org/057rd1163 | SCR_004081 | Biomol-Informatics SL | 2026-02-14 02:00:56 | 3 | |||||||
|
MPS Hamburg Resource Report Resource Website 1+ mentions |
MPS Hamburg (RRID:SCR_004087) | MPS | commercial organization | Full service Clinical Research Organization (CRO) in Hamburg, Germany, mainly focusing on phase-I and phase-IIa clinical trials. MPS owns 72 bed research clinic with 6 physicians and 15 nurses as permanent staff. MPS is experienced in performing all kind of early stage clinical trials, including first-in-man-trials, medical-devices-trials, nutraceutical and consumer-goods-trials. MPS holds active database of more than 17,000 healthy volunteers, plus hundreds of patients in special populations. | clinical trial, clinical, medical device, patient registry, healthy, nutraceutical, consumer-goods, pharmaceutical | is related to: European Gram Negative AntiBacterial Engine | nlx_158544 | SCR_004087 | MPS Hamburg GmbH | 2026-02-14 02:00:36 | 1 | ||||||||
|
Taros Resource Report Resource Website |
Taros (RRID:SCR_004119) | Taros | commercial organization | An independent contract research company that serves the needs of pharmaceutical, chemical, agrochemical and biotech companies, operating state-of-the art lab facilities and supporting the diverse needs of its customers in efficient drug discovery, medicinal chemistry and classical synthetic chemistry. Taros'' scientists combine more than 140 years industrial organic chemistry experience and over 60 years of active drug discovery experience from big pharmas and biotechs. They have expertise across a broad range of therapeutic areas (oncology, respiratory, CNS, cardiovascular, inflammation, pain, metabolism and infectious) and in all small molecule target classes. They have developed TarosGate, a unique software suite putting cost, time and chemistry information at a Project Leader''s finger tips. | custom synthesis, medicinal chemistry, drug discovery, computational chemistry, library synthesis, chemistry, organic chemistry, contract research organization, software |
is related to: European Lead Factory is parent organization of: European Lead Factory |
nlx_158596 | http://www.taros.de/cms/front_content.php?changelang=1&idart=1 http://www.tarosdiscovery.com/ |
SCR_004119 | Taros Chemicals GmbH, Taros Discovery, Taros Chemicals GmbH & Co. KG | 2026-02-14 02:00:56 | 0 | |||||||
|
Syncom Resource Report Resource Website 50+ mentions |
Syncom (RRID:SCR_004118) | Syncom | commercial organization | Independent contract research organization / small and medium sized enterprise (CRO/SME) that assists pharma and biotechnology companies with medicinal chemistry programs, providing tailor-made custom synthesis solutions. Primary activities include synthesis of key building blocks, route scouting services, process research activities, scale up, medicinal chemistry services and hit-to-lead optimization. On custom basis they also synthesize metabolites, impurities, reference standards and stable labelled compounds. Their services are backed up by state-of-the-art analytical technologies such as HPLC, GC, LC-MS, GC-MS and NMR. These technologies can be offered as stand-alone analytical services as well. Syncom also has expertise in chiral technology. The firm has designed and synthesized numerous unique scaffolds, yielding many patent applications and clinical candidates. Name changed to Symeres after merger with Mercachem., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | organic chemistry, custom synthesis, medicinal chemistry, chiral, metabolite, impurity, reference standard, compound, contract research organization | is related to: European Lead Factory | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158595 | SCR_004118 | Symeres, Syncom: Contract Research in Organic Chemistry, Syncom BV | 2026-02-14 02:00:40 | 81 | |||||||
|
Edelris Resource Report Resource Website 1+ mentions |
Edelris (RRID:SCR_004112) | Edelris | commercial organization | A commercial medicinal chemistry company dedicated to the design and synthesis of natural product-mimetic screening compounds, Hit-to-Lead & Lead Optimization projects and Custom Synthesis. Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its validated chemistry and drug discovery expertise to provide novelty to its customers with exclusive or non-exclusive small molecules and with efficient hit-to-lead optimization capabilities. EDELRIS has a wide range of services and based on its experience in various and complementary fields, the team is capable to deliver innovative solutions to synthetic and medicinal chemistry problems faced by clients. | screening compound, chemical, small molecule, drug discovery, natural product | is related to: European Lead Factory | nlx_158590 | SCR_004112 | 2026-02-14 02:00:55 | 2 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.
Email: info_at_ dknet.org
